Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: Some interesting findings since 2007

Immunohematology

Volumn 30, Issue 2, 2014, Pages 66-79

  Garratty, George ^a   Arndt, Patricia A ^a  

^a AMERICAN RED CROSS   (United States)

Author keywords

Autoantibody; Drug dependent antibody; Drugs; Immune hemolytic anemia; Nonimmunologic protein adsorption

Indexed keywords

ALEMTUZUMAB; ANTINEOPLASTIC AGENT; AUTOANTIBODY; CARBROMAL; CEFOTETAN; CEFPIROME; CEFTRIAXONE; CIMETIDINE; CYCLOSPORIN; DACLIZUMAB; DRUG ANTIBODY; DRUG DEPENDENT ANTIBODY; DRUG INDEPENDENT ANTIBODY; ETORICOXIB; FLUDARABINE; FUROSEMIDE; HYDROCORTISONE; IOMEPROL; METHADONE; MYCOPHENOLIC ACID; NORFLOXACIN; OXALIPLATIN; PIPERACILLIN; PUERARIN; PURINE DERIVATIVE; RITUXIMAB; SULFAMETHOXAZOLE; TACROLIMUS; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCRISTINE; ANTIINFECTIVE AGENT; IMMUNOSUPPRESSIVE AGENT; PLASMA PROTEIN;

ADSORPTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD DONOR; BLOOD GROUP; COOMBS TEST; DRUG INDUCED DISEASE; DRUG INDUCED IMMUNE HEMOLYTIC ANEMIA; DRUG INDUCED POSITIVE ANTIGLOBULIN TEST; FALSE POSITIVE RESULT; HUMAN; PRIORITY JOURNAL; TRANSPLANTATION; ANTIGEN ANTIBODY COMPLEX; BLOOD; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; ERYTHROCYTE; HEMOLYSIS; HISTORY; IMMUNOLOGY; ORGAN TRANSPLANTATION; REVIEW;

ADSORPTION; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTI-BACTERIAL AGENTS; ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; BLOOD PROTEINS; CELLS, CULTURED; COOMBS TEST; ERYTHROCYTES; HEMOLYSIS; HISTORY, 21ST CENTURY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; PIPERACILLIN;

EID: 84908620655     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (182)

1. Garratty G. Drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests. Immunohematology 1985; 2:1-8.
2. Garratty G. Current viewpoints on mechanisms causing drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests. Immunohematology 1989;5:97-106.
3. Garratty G. Review: immune hemolytic anemia and/or positive direct antiglobulin tests caused by drugs. Immunohematology 1994;10:41-50.
4. Garratty G. Review: drug-induced immune hemolytic anemia; the last decade. Immunohematology 2004;20:138-46.
5. Garratty G, Arndt PA. An update on drug-induced immune hemolytic anemia. Immunohematology 2007;23:105-19.
6. Arndt PA. Drug-induced immune hemolytic anemia: the last 30 years of changes. Immunohematology 2014;30:44-54.
7. Leger RM, Arndt PA, Garratty G. How we investigate drug-induced immune hemolytic anemia. Immunohematology 2014;30:85-94.
8. Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia, PA: Churchill Livingstone, 2004.
9. Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program 2009:73-9.
10. Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev 2010;24:143-50.
11. Garratty G. Drug-induced immune hemolytic anemia. Clin Adv Hematol Oncol 2010;8:98-101.
12. Garratty G. Immune hemolytic anemia caused by drugs. Expert Opin Drug Saf 2012;11:635-42.
13. Johnson ST, Fueger JT, Gottschall JL. One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia-a new paradigm. Transfusion 2007;47: 697-702.
14. Madoz P, Muñiz-Diaz E, Martinez C, et al. Fatal immune hemolytic anemia induced by aceclofenac (abstract). Transfusion 1997;37:36S.
15. Manor E, Marmor A, Kaufman S, Leiba H. Massive hemolysis caused by acetaminophen. Positive determination by direct Coombs test. JAMA 1976;236:2777-8.
16. Garratty G, Stuart B, Postoway N, Bueno R. Antibodies to acetaminophen/phenacetin in normal donors, unselected hospital patients, and a patient with intravascular hemolysis, thrombocytopenia, and renal failure (abstract). Transfusion 1980;20:648.
17. González CA, Guzmán L, Nocetti G. Drug-dependent antibodies with immune hemolytic anemia in AIDS patients. Immunohematology 2003;19:10-15.
18. Bernasconi C, Bedarida G, Pollini G, Sartori S. Study of the mechanism of hemolysis in a case of acquired hemolytic anemia caused by pyramidon (in Italian). Haematologica 1961;46:697-720.
19. Gmür J, Wälti M, Neftel KA. Amoxicillin-induced immune hemolysis. Acta Haematol 1985;74:230-3.
20. Salama A, Burger M, Mueller-Eckhardt C. Acute immune hemolysis induced by a degradation product of amphotericin B. Blut 1989;58:59-61.
21. Thomson S, Williamson D. A case of ampicillin-induced haemolytic anemia. Can J Med Technol 1974;36:228-9.
22. Bengtsson U, Ahlstedt S, Aurell M, Kaijser B. Antazoline-induced immune hemolytic anemia, hemoglobinuria, and acute renal failure. Acta Med Scand 1975;198:223-7.
23. Hubert D, Habibi B, Krulik M, Debray J. Immunoallergic hemolytic anemia with thrombocytopenia and acute renal failure induced by aspirin (in French). Presse Med 1984;13:2567-9.
24. Bird GWG, Wingham J, Babb RG, Bacon P, Wood D. Azapropazone-associated antibodies. Vox Sang 1984;46: 336-7.
25. Salama A, Mueller-Eckhardt C, Kissel K, Pralle H, Seeger W. Ex vivo antigen preparation for the serological detection of drug-dependent antibodies in immune haemolytic anaemias. Br J Haematol 1984;58:525-31.
26. Salama A, Northoff H, Burkhardt H, Mueller-Eckhardt C. Carbimazole-induced immune haemolytic anaemia: role of drug-red blood cell complexes for immunization. Br J Haematol 1988;68:479-82.
27. Maloisel F, Kurtz JE, Andres E, Gorodetsky C, Dufour P, Oberling F. Platin salts-induced hemolytic anemia: cisplatin-and the first case of carboplatin-induced hemolysis. Anticancer Drugs 1995;6:324-6.
28. Stefanini M, Johnson NL. Positive antihuman globulin test in patients receiving carbromal. Am J Med Sci 1970;259:49-55.
29. Salama A, Mueller-Eckhardt C. Cianidanol and its metabolites bind tightly to red cells and are responsible for the production of auto-and/or drug-dependent antibodies against these cells. Br J Haematol 1987;66:263-6.
30. Branch DR, Berkowitz LR, Becker RL, et al. Extravascular hemolysis following the administration of cefamandole. Am J Hematol 1985;18:213-19.
31. Moake JL, Butler CF, Hewell GM, Cheek J, Spruell MA. Hemolysis induced by cefazolin and cephalothin in a patient with penicillin sensitivity. Transfusion 1978;18:369-73.
32. Malaponte G, Arcidiacono C, Mazzarino C, et al. Cephalosporin-induced hemolytic anemia in a Sicilian child. Hematology 2000;5:327-34.
33. Salama A, Göttsche B, Schleiffer T, Mueller-Eckhardt C. "Immune complex" mediated intravascular hemolysis due to IgM cephalosporin dependent antibody. Transfusion 1987;27:460-3.
34. Eckrich RJ, Fox S, Mallory D. Cefotetan-induced immune hemolytic anemia due to the drug-adsorption mechanism. Immunohematology 1994;10:51-4.
35. Garratty G, Nance S, Lloyd M, Domen R. Fatal immune hemolytic anemia due to cefotetan. Transfusion 1992;32: 269-71.
36. Arndt PA, Leger RM, Garratty G. Serology of antibodies to second-and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Transfusion 1999;39:1239-46.
37. Viraraghavan R, Chakravarty AG, Soreth J. Cefotetan-induced haemolytic anaemia. A review of 85 cases. Adverse Drug React Toxicol Rev 2002;21:101-7.
38. Davenport RD, Judd WJ, Dake LR. Persistence of cefotetan on red blood cells. Transfusion 2004;44:849-52.
39. Toy E, Nesbitt R, Savastano G, Fox S, Araneta M, Hsueh Y. Warm autoantibody following plasma apheresis complicated by acute intravascular hemolysis associated with cefoxitin-dependent antibody resulting in fatality (abstract). Transfusion 1989;29:51S.
40. Novaretti MCZ, Sopeleti CR, Dorlhiac-Llacer PE, Chamone DA. Use of gel microcolumn assay for the detection of drug-induced positive direct antiglobulin tests. J Clin Lab Anal 2005;19:219-27.
41. Chambers LA, Donovan LM, Kruskall MS. Ceftazidime-induced hemolysis in a patient with drug-dependent antibodies reactive by immune complex and drug adsorption mechanisms. Am J Clin Pathol 1991;95:393-6.
42. Shammo JM, Calhoun B, Mauer AM, Hoffman PC, Baron JM, Baron BW. First two cases of immune hemolytic anemia associated with ceftizoxime. Transfusion 1999;39:838-44.
43. Garratty G, Postoway N, Schwellenbach J, McMahill PC. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis. Transfusion 1991;31:176-9.
44. Seltsam A, Salama A. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med 2000;26:1390-4.
45. Malloy CA, Kiss JE, Challapalli M. Cefuroxime-induced immune hemolysis. J Pediatr 2003;143:130-2.
46. Manoharan A, Kot T. Cephalexin-induced haemolytic anaemia (letter). Med J Aust 1987;147:202.
47. Gralnick HR, Wright LD Jr, McGinniss MH. Coombs' positive reactions associated with sodium cephalothin therapy. JAMA 1967;199:725-6.
48. Molthan L, Reidenberg MM, Eichman MF. Positive direct Coombs tests due to cephalothin. N Engl J Med 1967;277: 123-5.
49. Gralnick HR, McGinniss M, Elton W, McCurdy P. Hemolytic anemia associated with cephalothin. JAMA 1971;217:1193-7.
50. Giro C, Verlicchi G, Baccarani M. Selective erythroblastic aplasia and hemolytic immunopathic type complement anemia in a patient treated with chloramphenicol (in Italian). G Clin Med 1970;51:112-18.
51. Muirhead EE, Groves M, Guy R, Halden ER, Bass RK. Acquired hemolytic anemia, exposures to insecticides and positive Coombs' test dependent on insecticide preparations. Vox Sang 1959;4:277-92.
52. Lindberg LG, Norden A. Severe hemolytic reaction to chlorpromazine. Acta Med Scand 1961;170:195-9.
53. Logue GL, Boyd AE 3rd, Rosse WF. Chlorpropamide-induced immune hemolytic anemia. N Engl J Med 1970;283:900-4.
54. Sosler SD, Behzad O, Garratty G, Lee CL, Postoway N, Khomo O. Acute hemolytic anemia associated with a chlorpropamide-induced apparent auto anti-Jka. Transfusion 1984;24:206-9.
55. Arndt PA, Garratty G, Brasfield FM, Vemuri SL, Asuncion DJ. Immune hemolytic anemia due to cimetidine: the first example of a cimetidine antibody. Transfusion 2010;50:302-7.
56. MacKay AD, Mehta A. Autoimmune haemolytic anaemia associated with ciprofloxacin. Clin Lab Haematol 1995;17: 97-8.
57. Getaz EP, Beckley S, Fitzpatrick J, Dozier A. Cisplatin-induced hemolysis. N Engl J Med 1980;302:334-5.
58. Zeger G, Smith L, McQuiston D, Goldfinger D. Cisplatin-induced nonimmunologic adsorption of immunoglobulin by red cells. Transfusion 1988;28:493-5.
59. Schroeder ML, Taylor M, Anderson C, Albritton WL. Immune hemolysis in an infant with a staphylococcal infection (abstract). International Society of Blood Transfusion, Montreal, Canada 1980.
60. Barbolla L, Fernandez MN, Bajo R, Arrieta R, Gilsanz F. Positive Coombs' test due to synthetic estrogen therapy (bis(p-acetyloxiphenyl-cyclohexilydene)-methane) (in Spanish). Sangre 1974;19:99-104.
61. De Vecchi A, Zanella A, Egidi F, Ponticelli C. Autoimmune hemolytic anemia in a cadaveric renal transplant recipient treated with cyclosporine. Acta Haematol 1985;73:216-18.
62. Duran-Suarez JR, Martin-Vega C, Argelagues E, et al. The I antigen as an immune complex receptor in a case of haemolytic anaemia induced by an antihistaminic agent. Br J Haematol 1981;49:153-4.
63. Ciucci AG. A review of spontaneously reported adverse drug reactions with diclofenac sodium (Voltarol). Rheumatol Rehabil 1979;(Suppl2):116-21.
64. Salama A, Göttsche B, Mueller-Eckhardt C. Autoantibodies and drug-or metabolite-dependent antibodies in patients with diclofenac-induced immune haemolysis. Br J Haematol 1991;77:546-9.
65. Salama A, Kroll H, Wittmann G, Mueller-Eckhardt C. Diclofenac-induced immune haemolytic anaemia: simul-taneous occurrence of red blood cell autoantibodies and drug-dependent antibodies. Br J Haematol 1996;95:640-4.
66. Ahrens N, Genth R, Kiesewetter H, Salama A. Misdiagnosis in patients with diclofenac-induced hemolysis: new cases and a concise review. Am J Hematol 2006;81:128-31.
67. Rosenfeld CS, Winters SJ, Tedrow HE. Diethylstilbestrol-associated hemolytic anemia with a positive direct antiglobulin test result. Am J Med 1989;86:617-8.
68. Lay WH. Drug-induced haemolytic reactions due to antibodies against the erythrocyte/dipyrone complex. Vox Sang 1966; 11:601-10.
69. Wong KY, Boose GM, Issitt CH. Erythromycin-induced hemolytic anemia. J Pediatr 1981;98:647-9.
70. Cunha PD, Lord RS, Johnson ST, Wilker PR, Aster RH, Bougie DW. Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac, a nonsteroidal anti-inflammatory drug. Transfusion 2000;40:663-8.
71. Mayer B, Genth R, Dehner R, Salama A. The first example of a patient with etoricoxib-induced immune hemolytic anemia. Transfusion 2013;53:1033-6.
72. Shirey RS, Morton SJ, Lawton KB, Lowell C, Kickler TS, Ness PM. Fenoprofen-induced immune hemolysis: difficulties in diagnosis and complications in compatibility testing. Am J Clin Pathol 1988;89:410-14.
73. Munizza M, Kavitsky D, Schainker BA, Poyser A, Peek C, Nance S. Hemolytic anemia associated with injection of fluorescein. Transfusion 1993;33:689-92.
74. Sandvei P, Nordhagen R, Michaelsen TE, Wolthuis K. Fluorouracil (5-FU) induced acute immune haemolytic anaemia. Br J Haematol 1987;65:357-9.
75. Habibi B. Drug induced red blood cell autoantibodies co-developed with drug specific antibodies causing haemolytic anaemias. Br J Haematol 1985;61:139-43.
76. Vassal T, Lentzy M, Maury E, Guidet B, Offenstadt G. Severe immunoallergic hemolytic anemia caused by a glafenine metabolite (in French). Presse Med 1991;20:1434-6.
77. Orenstein AA, Yakulis V, Eipe J, Costea N. Immune hemolysis due to hydralazine (letter). Ann Intern Med 1977;86:450-1.
78. Vila JM, Blum L, Dosik H. Thiazide-induced immune hemolytic anemia. JAMA 1976;236:1723-4.
79. Criel AM, Hidajat M, Clarysse A, Verwilghen RL. Drug dependent red cell antibodies and intravascular haemolysis occurring in patients treated with 9-hydroxy-methyl-ellipticinium. Br J Haematol 1980;46:549-56.
80. Martinengo M, Ardenghi DF, Tripodi G, Reali G. The first case of drug-induced immune hemolytic anemia due to hydrocortisone. Transfusion 2008;48:1925-9.
81. Korsager S. Haemolysis complicating ibuprofen treatment. Br Med J 1978;1:79.
82. Novaretti MCZ, Fonseca GHH, Conchon M, Dorlhiac-Llacer PE, Chamone DAF. First case of immune-mediated haemolytic anaemia associated to imatinib mesylate. Eur J Haematol 2003;71:455-8.
83. Faulk WP, Tomsovic EJ, Fudenberg HH. Insulin resistance in juvenile diabetes mellitus. Am J Med 1970;49:133-9.
84. Mayer B, Leo A, Herziger A, Houben P, Schemmer P, Salama A. Intravascular immune hemolysis caused by the contrast medium iomeprol. Transfusion 2013;53:2141-4.
85. Robinson MG, Foadi A. Hemolytic anemia with positive Coombs' test. Association with isoniazid therapy. JAMA 1969; 208:656-8.
86. Oh YR, Carr-Lopez SM, Probasco JM, Crawley PG. Levofloxacin-induced autoimmune hemolytic anemia. Ann Pharmacother 2003;37:1010-13.
87. Arndt PA, Garratty G, Maranto LS, Wohl H. Immune hemolytic anemia associated with mefloquine (letter). Transfusion 1997; 37:1220-1.
88. Eyster ME. Melphalan (Alkeran) erythrocyte agglutinin and hemolytic anemia. Ann Intern Med 1967;66:573-7.
89. Pujol M, Fernández F, Sancho JM, Ribera JM, Millá F, Feliu E. Immune hemolytic anemia induced by 6-mercaptopurine. Transfusion 2000;40:75-6.
90. Sivamurthy S, Frankfurt E, Levine ME. Positive antiglobulin tests in patients maintained on methadone. Transfusion 1973; 13:418-21.
91. Woolley PV 3rd, Sacher RA, Priego VM, Schanfield MS, Bonnem EM. Methotrexate-induced immune haemolytic anaemia. Br J Haematol 1983;54:543-52.
92. Nordhagen R, Vik H, Wolthuis K, Bohn HP, Urdahl P, Michaelsen TE. Immune-mediated hemolysis associated with the administration of a radiographic contrast medium. Transfusion 1991;31:843-6.
93. Kudoh T, Nagata N, Suzuki N, Nakata S, Chiba S, Takahashi T. Minocycline-induced hemolytic anemia. Acta Paediatr Jpn 1994;36:701-4.
94. Johnson ST, Bandouveres S, Aster RH, Bougie D. Nabumetone metabolite-dependent antibody reacting with untreated red cells in the presence of urinary metabolite (abstract). Transfusion 2003;43:101A.
95. Kroovand S, Kirtland HH, Issitt CH. A positive direct antiglobulin test due to sodium nafcillin (abstract). Transfusion 1977;17:682.
96. Lo TZH, Martin MA. Autoimmune haemolytic anaemia associated with naproxen suppositories. BMJ 1986;292:1430.
97. Duran-Suarez JR, Martin-Vega C, Argelagues E, Massuet L, Ribera A, Triginer J. Red cell I antigen as immune complex receptor in drug-induced hemolytic anemias. Vox Sang 1981;41:313-15.
98. Bournerias F, Nabibi B. Nomifensine-induced immune haemolytic anaemia and impaired renal function (letter). Lancet 1979;2:95-6.
99. Abad A, López P, Bauza J. Norfloxacin-induced positive direct antiglobulin test (letter). Vox Sang 1999;77:238.
100. Desrame J, Broustet H, Darodes de Tailly P, Girard D, Saissy JM. Oxaliplatin-induced haemolytic anaemia. Lancet 1999;354:1179-80.
101. Arndt PA, Garratty G, Isaak E, Bolger M, Lu Q. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption. Transfusion 2009;49:711-18.
102. MacGibbon BH, Loughridge LW, Hourihane DO, Boyd DW. Autoimmune haemolytic anaemia with acute renal failure due to phenacetin and p-aminosalicylic acid. Lancet 1960;1:7-10.
103. Park GM, Han KS, Chang YH, Kim CH, Lee JC. Immune hemolytic anemia after treatment with pemetrexed for lung cancer (letter). J Thorac Oncol 2008;3:196-7.
104. Strumia PV, Raymond FD. Acquired hemolytic anemia and antipenicillin antibody. Case report and review of literature. Arch Intern Med 1962;109:603-8.
105. Petz LD, Fudenberg HH. Coombs-positive hemolytic anemia caused by penicillin administration. N Engl J Med 1966; 274:171-8.
106. Muirhead EE, Halden ER, Groves M. Drug-dependent Coombs (antiglobulin) test and anemia; observations on quinine and acetophenetidin (phenacetin). Arch Intern Med 1958;101: 87-96.
107. Johnson ST, Weitekamp LA, Sauer DE, Fueger JT, Aster RH. Piperacillin-dependent antibody with relative e specificity reacting with drug treated red cells and untreated red cells in the presence of drug (abstract). Transfusion 1994;34:70S.
108. Sosler SD, Behzad O, Garratty G, Lee CL, Postoway N, Khomo O. Immune hemolytic anemia associated with probenecid. Am J Clin Pathol 1985;84:391-4.
109. Rubio-Martínez A, García-Erce JA, Salvador C, Gómez-Arteta E, Gimeno JJ. Autoimmune haemolytic anaemia induced by propyphenazone (letter). Vox Sang 1998;75:257.
110. Chen F, Liu S, Wu J. Puerarin-induced immune hemolytic anemia. Int J Hematol 2013;98:112-13.
111. Freedman AL, Barr PS, Brody EA. Hemolytic anemia due to quinidine: observations on its mechanism. Am J Med 1956; 20:806-16.
112. Pixley JS, MacKintosh FR, Sahr EA, Zanjani ED. Mechanism of ranitidine associated anemia. Am J Med Sci 1989;297: 369-71.
113. Blajchman MA, Lowry RC, Pettit JE, Stradling P. Rifampicin-induced immune thrombocytopenia. Br Med J 1970;3:24-6.
114. Worlledge S. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative Study of rifampicin plus ethambutol in daily and intermittent regimens. The detection of rifampicin-dependent antibodies. Scand J Respir Dis 1973;84:60-3.
115. Worlledge S. Hong Kong Treatment Services-Royal Post-graduate Medical School-British Medical Research Council Co-operative Study of rifampicin plus ethambutol in daily and intermittent regimens. Correlation between the presence of rifampicin-dependent antibodies and the clinical data. Scand J Respir Dis 1973;84:125-8.
116. Harris JW. Studies on the mechanism of a drug-induced hemolytic anemia. J Lab Clin Med 1956;47:760-75.
117. Mathiesen O, Grunnet N. Haemolysis after intravenous streptokinase (letter). Lancet 1989;1:1016-17.
118. Letona JM, Barbolla L, Frieyro E, Bouza E, Gilsanz F, Fernández MN. Immune haemolytic anaemia and renal failure induced by streptomycin. Br J Haematol 1977;35:561-71.
119. Florendo NT, MacFarland D, Painter M, Muirhead EE. Streptomycin-specific antibody coincident with a developing warm autoantibody. Transfusion 1980;20:662-8.
120. Fernández MN, Barbolla L. Streptomycin-specific antibodies (letter). Transfusion 1982;22:344-5.
121. Teplitsky V, Virag I, Halabe A. Immune complex haemolytic anaemia associated with sulfasalazine. BMJ 2000;320:1113.
122. Johnson FP Jr, Hamilton HE, Liesch MR. Immune hemolytic anemia associated with sulindac. Arch Intern Med 1985;145:1515-16.
123. van Dijk BA, Rico PB, Hoitsma A, Kunst VA. Immune hemolytic anemia associated with tolmetin and suprofen. Transfusion 1989;29:638-41.
124. Law IP, Wickman CJ, Harrison BR. Coombs'-positive hemolytic anemia and ibuprofen. South Med J 1979;72: 707-10.
125. Coluccio E, Villa MA, Villa E, et al. Immune hemolytic anemia associated with teicoplanin. Transfusion 2004;44:73-6.
126. Maguire RB, Stroncek DF, Gale E, Yearlsey M. Hemolytic anemia and acute renal failure associated with temafloxacin-dependent antibodies. Am J Hematol 1994;46:363-6.
127. Habibi B, Lopez M, Serdaru M, et al. Immune hemolytic anemia and renal failure due to teniposide. N Engl J Med 1982;306:1091-3.
128. Wenz B, Klein RL, Lalezari P. Tetracycline-induced immune hemolytic anemia. Transfusion 1974;14:265-9.
129. Habibi B, Basty R, Chodez S, Prunat A. Thiopental-related immune hemolytic anemia and renal failure. Specific involvement of red-cell antigen I. N Engl J Med 1985;312: 353-5.
130. Arndt PA, Wolf CF, Kripas CJ, Garratty G. First example of an antibody to ticarcillin: a possible cause of hemolytic anemia (abstract). Transfusion 1999;39:47S.
131. Bird GW, Eeles GH, Litchfield JA, Rahman M, Wingham J. Haemolytic anaemia associated with antibodies to tolbutamide and phenacetin. Br Med J 1972;1:728-9.
132. Leitman SF, Lee BJ, McGinniss MH, Shulman NR, Frank MM. Massive immune hemolysis, disseminated intravascular coagulation (DIC), and acute renal failure in association with tolmetin ingestion (abstract). Transfusion 1984;24:426.
133. Takahashi H, Tsukada T. Triamterene-induced immune haemolytic anaemia with acute intravascular haemolysis and acute renal failure. Scand J Haematol 1979;23:169-76.
134. Ahmad D, Morgan WK, Patterson R, Williams T, Zeiss CR. Pulmonary haemorrhage and haemolytic anaemia due to trimellitic anhydride. Lancet 1979;2:328-30.
135. Ermis B, Caner I, Karacan M, Olgun H. Haemolytic anaemia secondary to trimethoprim/sulfamethoxazole use (letter). Thromb Haemost 2003;90:158-9.
136. Betensky M, Fisher MJ, Nance SJ, Weiss M, Witmer C, Sesok-Pizzini D. Carboplatin and vincristine induced hemolytic anemia in a pediatric patient with an optic pathway glioma (abstract). Transfusion 2013;(53Suppl):32A.
137. Schulenburg BJ, Beck ML, Pierce SR, Plapp FV, Cooper DG. Immune hemolysis associated with ZomaxTM (abstract). Transfusion 1983;23:409.
138. Elimelakh M, Dayton V, Park KS, et al. Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenalate, and daclizumab in pancreas transplant recipients. Haematologica 2007;92: 1029-36.
139. Goldschmidt N, Gural A, Ben-Yehuda D, Gatt ME. Short communication: bendamustine-related hemolytic anemia in chronic lymphocytic leukemia. Cancer Chemother Pharmacol 2013;72:709-13.
140. Luderer JR, Schoolwerth AC, Sinicrope RA, Ballard JO, Lookingbill DP, Hayes AH Jr. Acute renal failure, hemolytic anemia and skin rash associated with captopril therapy. Am J Med 1981;71:493-6.
141. Tregellas WM, South SF. Autoimmune syndrome induced by chaparral ingestion (abstract). Transfusion 1980;20:647-8.
142. Rotoli B, Formisano S, Alfinito F. Autoimmune haemolytic anaemia associated with cimetidine (letter). Lancet 1979;2:583.
143. Fleischman RA, Croy D. Acute onset of severe autoimmune hemolytic anemia after treatment with 2-chlorodeoxyadenosine for chronic lymphocytic leukemia (letter). Am J Hematol 1995; 48:293.
144. Nussey AM. Fenfluramine and haemolytic anaemia (letter). Br Med J 1973;1:177-8.
145. Bastion Y, Coiffier B, Dumontet C, Espinouse D, Bryon PA. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia (letter). Ann Oncol 1992;3:171-2.
146. Di Raimondo F, Giustolisi R, Cacciola E, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine. Leuk Lymphoma 1993;11:63-8.
147. Akard LP, Hoffman R, Elias L, Saiers JH. Alpha-interferon and immune hemolytic anemia (letter). Ann Intern Med 1986; 105:306-7.
148. Perez R, Padavic K, Krigel R, Weiner L. Antierythrocyte autoantibody formation after therapy with interleukin-2 and gamma-interferon. Cancer 1991;67:2512-17.
149. Umstead GS, Babiak LM, Tejwani S. Immune hemolytic anemia associated with ketoconazole therapy. Clin Pharm 1987;6:499-500.
150. Darabi K, Kantamnei S, Wiernik PH. Lenalidomide-induced warm autoimmune hemolytic anemia. J Clin Oncol 2006; 24:e59.
151. Cotzias GC, Papavasiliou PS. Autoimmunity in patients treated with levodopa (letter). JAMA 1969;207:1353-4.
152. Scott GL, Myles AB, Bacon PA. Autoimmune haemolytic anaemia and mefenamic acid therapy. Br Med J 1968;3:534-5.
153. Snapper I, Marks D, Schwartz L, Hollander L. Hemolytic anemia secondary to mesantoin. Ann Intern Med 1953;39: 619-23.
154. Carstairs K, Worlledge S, Dollery CT, Breckenridge A. Methyldopa and haemolytic anaemia (letter). Lancet 1966; 1:201.
155. Gilbertson C, Jones DR. Haemolytic anaemia with nalidixic acid (letter). Br Med J 1972;4:493. 156 Jones GW, George TL, Bradley RD. Procainamide-induced hemolytic anemia. Transfusion 1978;18:224-7.
156. Jones GW, George TL, Bradley RD. Procainamide-induced hemolytic anemia. Transfusion 1978;18:224-7
157. Kleinman S, Nelson R, Smith L, Goldfinger D. Positive direct antiglobulin tests and immune hemolytic anemia in patients receiving procainamide. N Engl J Med 1984;311:809-12.
158. Jourdan E, Topart D, Richard B, Jourdan J, Sotto A. Severe autoimmune hemolytic anemia following rituximab therapy in a patient with a lymphoproliferative disorder. Leuk Lymphoma 2003;44:889-90.
159. DiGiuseppe JA, Bastacky SI, Shirey RS, Silberman MA, Hutchins GM, Ness PM. Tacrolimus-related posttransplant lymphoproliferative disorder presenting as autoimmune hemolytic anemia. Arch Pathol Lab Med 1996;120:282-5.
160. Shen Y. Autoimmune hemolytic anemia associated with a formulation of traditional Chinese medicines. Am J Health-Syst Pharm 2009;66:1701-3.
161. Williams ME, Thomas D, Harman CP, Mintz PD, Donowitz GR. Positive direct antiglobulin tests due to clavulanic acid. Antimicrob Agents Chemother 1985;27:125-7.
162. Garratty G, Arndt PA. Positive direct antiglobulin tests and haemolytic anaemia following therapy with beta-lactamase inhibitor containing drugs may be associated with nonimmunologic adsorption of protein onto red blood cells. Br J Haematol 1998;100:777-83.
163. Smith RL, Gralnick MA, Cysyk RL, Gralnick HR. Red cell alterations by a new chemotherapeutic agent (abstract). Transfusion 1974;14:513.
164. Jamin D, Demers J, Shulman I, Lam HT, Momparler R. An explanation for nonimmunologic adsorption of proteins onto red blood cells: Schiff's base reactions. Blood 1986;67:993-6.
165. Lutz P, Dzik W. Very high incidence of a positive direct antiglobulin test (+DAT) in patients receiving Unasyn (abstract). Transfusion 1992;32:23S.
166. Jamin D, Shulman I, Lam HT, et al. Production of a positive direct antiglobulin test due to suramin. Arch Pathol Lab Med 1988;112:898-900.
167. Broadberry RE, Farren TW, Bevin SV, et al. Tazobactam-induced haemolytic anaemia, possibly caused by non-immunological adsorption of IgG on patient's red cells. Transfus Med 2004;14:53-7.
168. Arndt PA, Leger RM, Garratty G. Positive direct antiglobulin tests and haemolytic anaemia following therapy with the beta-lactamase inhibitor, tazobactam, may also be associated with non-immunologic adsorption of protein onto red blood cells (letter). Vox Sang 2003;85:53.
169. Salama A, Mayer B. Diagnostic pitfalls of drug-induced hemolytic anemia. Immunohematology 2014;30:80-84.
170. Habibi B, Bretagne Y. Blood group antigens may be the receptors for specific drug-antibody complexes reacting with red blood cells (in French). CR Seances Acad Sc III 1983;296:693-6.
171. Salama A, Mueller-Eckhardt C. Rh blood group-specific antibodies in immune hemolytic anemia induced by nomifensine. Blood 1986;68:1285-8.
172. Arndt PA, Revilla J, Leger RM, Garratty G. Studies on specificity of selected drug-dependent antibodies (abstract). Transfusion 2013;(53Suppl):17A.
173. Leger RM, Arndt PA, Garratty G. Serological studies of piperacillin antibodies. Transfusion 2008;48:2429-34.
174. Leger RM, Garratty G. Antibodies to oxaliplatin, a chemotherapeutic, are found in plasma of healthy blood donors. Transfusion 2011;51:1740-4.
175. Arndt PA, Leger RM, Garratty G. IgM agglutinins to meropenem, a beta-lactam antibiotic, are found in plasma of healthy blood donors and random patients (abstract). Transfusion 2012;(52Suppl):26A.
176. Hamblin TJ, Orchard JA, Myint H, Oscier DG. Fludarabine and hemolytic anemia in chronic lymphocytic leukemia. J Clin Oncol 1998;16:3209-10.
177. Myint H, Copplestone JA, Orchard J, et al. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. Br J Haematol 1995;91:341-4.
178. Gonzalez H, Leblond V, Azar N, et al. Severe autoimmune hemolytic anemia in eight patients treated with fludarabine. Hematol Cell Ther 1998;40:113-18.
179. Dearden C, Wade R, Else M, et al.; UK National Cancer Research Institute (NCRI); Haematological Oncology Clinical Studies Group; NCRI CLL Working Group. The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. Blood 2008;111:1820-6.
180. Hamblin TJ. Autoimmune complications of chronic lympho-cytic leukemia. Semin Oncol 2006;33:230-9.
181. Borthakur G, O'Brien S, Wierda WG, et al. Immune anaemias in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide and rituximab-incidence and predictors. Br J Haematol 2007;136:800-5.
182. Glance LE, Cumpston A, Kanate A, Remick SC. Bendamustine-associated hemolytic anemia. Ann Pharmacol 2009;43: 1903-6.